Cyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting

Author's Avatar
Jan 04, 2023

Cyclo+Therapeutics%2C+Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced its abstract has been accepted for poster presentation at the Society+for+Inherited+Metabolic+Disorders+%28SIMD%29+44th+Annual+Meeting being held March 18 - 21, 2023, in Salt Lake City, Utah.